The field of spondyloarthritis (SpA) has undergone remarkable changes over the last decade, triggered by the increasing availability of MRI machines, the advent of effective targeted therapies and more refined criteria for classification and assessment.
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.